
Gamma CRO is a data management and AI solutions provider specifically for biotechs, aiming to reduce trial costs and timelines while enhancing drug development insights. They offer a range of services including project management from trial start to database closure, CRF design and development using a proprietary tool, database design and validation, medical dictionary coding, query generation and resolution, and database quality check and closure. Gamma CRO also provides insights with AI Agents and strategic staff augmentation, offering experts in Clinical Data Analysis, AI/ML/LLM, Project Management, Data Management, and Biostatistics, with staffing available in India, Canada, UK, or the US. Their product offerings include a Collaborative CRF Designer, a Trial Site Database, and a Portal for site personnel training and communication. They differentiate themselves by providing proactive project teams, quality deliverables, and cost-effective solutions tailored to the unique needs and budget constraints of biotechs, which traditional CROs often neglect.

Gamma CRO is a data management and AI solutions provider specifically for biotechs, aiming to reduce trial costs and timelines while enhancing drug development insights. They offer a range of services including project management from trial start to database closure, CRF design and development using a proprietary tool, database design and validation, medical dictionary coding, query generation and resolution, and database quality check and closure. Gamma CRO also provides insights with AI Agents and strategic staff augmentation, offering experts in Clinical Data Analysis, AI/ML/LLM, Project Management, Data Management, and Biostatistics, with staffing available in India, Canada, UK, or the US. Their product offerings include a Collaborative CRF Designer, a Trial Site Database, and a Portal for site personnel training and communication. They differentiate themselves by providing proactive project teams, quality deliverables, and cost-effective solutions tailored to the unique needs and budget constraints of biotechs, which traditional CROs often neglect.